Anthony S. Gibney - Apr 15, 2024 Form 4 Insider Report for Clearside Biomedical, Inc. (CLSD)

Role
Director
Signature
/s/ Mark Ballantyne, Attorney-in-Fact
Stock symbol
CLSD
Transactions as of
Apr 15, 2024
Transactions value $
$0
Form type
4
Date filed
4/16/2024, 04:31 PM
Previous filing
Jul 13, 2023
Next filing
Apr 19, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CLSD Stock Option (right to buy) Award $0 +45K $0.00 45K Apr 15, 2024 Common Stock 45K $1.29 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares underlying such option will vest in 36 equal monthly installments on the last day of each month commencing on April 30, 2024, subject to the Reporting Person's continuous service through each vesting date.